Life Science & Healthcare

Manchester offers a unique opportunity to life science companies. The only devolved health and social care system in the UK, companies can benefit from a streamlined innovation adoption pathway to deliver health innovations to over 11.8 million patients.

A city of firsts, Manchester introduced In Vitro Fertilisation (IVF) to the world enabling over 8 million babies to be born and pioneered hip replacement surgery and bionic eye implants. Still a hub of innovation the city is now home to world leading research and development assets as well as the largest clinical academic campus in Europe.

As well as innovation, businesses based here can benefit from easy connectivity to global healthcare hubs as well as an experienced and diverse talent pool. The city’s four universities provide a steady supply of graduates in addition to establishing research collaborations with organisations globally.

For businesses looking to deliver innovation at pace and scale MIDAS - Manchester’s inward investment agency, can offer free confidential advice, help you engage with the globally renowned research centres, and enable you to establish a foothold in one of Europe’s top business destinations.

Deliver innovation at pace and scale

The NHS provides care for 64.6 million people in the UK covering everything from general practice to emergency treatment and antenatal screenings. Manchester is home to over 30 NHS organisations including The Christie; a hospital renowned as a world pioneer in the care, treatment and research of cancer, Salford Royal NHS Trust; the only fully e-enabled NHS trust in England and the largest children’s hospital in the UK.

Manchester is the only UK city to have devolved control of its £6bn health and social care budget. As a devolved health care system, city leaders have developed a streamlined innovation pathway to deliver innovations at pace and scale across the city’s 2.8 million citizens and additional 9 million people in the health catchment area. Innovations which deliver the most benefit to the most prevalent diseases are being prioritised across are being prioritised across oncology, cardio-vascular disease and diabetes.

Specialist strengths

Manchester has range of specialists which work together to create an innovation ecosystem which is greater than the sum of its parts.

Click below to find out more about each strength:

- Health analytics and MedTech

- Precision medicine

In addition to these sub sector strengths the city is also a world scientific lead in cancer biomarkers, the molecular targeting of cancer, early-phase clinical trials and cutting-edge radiotherapy. Manchester is also a global destination for advanced materials and digital, giving businesses the opportunity to explore medical applications of graphenes and 2D materials as well as emerging technologies such as VR and AR.

Get in touch

To find out more about how MIDAS can help your business move to Manchester, get in touch with the team today. You can also keep up-to-date with us via Twitter and LinkedIn.